Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FPNSD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $60,942
Award facts
- Contract value 100% obligated
- $60,941.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BIKTARVY 50-200-25 mg tablets (quantity: 30-count packages) valued at approximately $60,941.83 under a firm fixed-price contract type. The award was made on September 11, 2025, with an ultimate completion date of September 12, 2025, with performance to take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was not designated as a set-aside and was competitively awarded. BIKTARVY is an HIV treatment medication, reflecting the breadth of pharmaceutical products procured by DLA to support military and federal healthcare systems.
This delivery order is a child contract under AmerisourceBergen Drug Corp's significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and related healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement and maintains a robust portfolio of competitively awarded contracts with DLA for diverse pharmaceutical and medical supply deliveries to support Defense Health Agency operations and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FPNSD?
SPE2DB25FPNSD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FPNSD worth?
The government has obligated $60,942 on SPE2DB25FPNSD.
Is contract SPE2DB25FPNSD an order under another contract?
Yes. SPE2DB25FPNSD is a delivery order under SPE2DB20D2001, an indefinite delivery contract.
Was contract SPE2DB25FPNSD competed?
The extent of competition for SPE2DB25FPNSD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award